Literature DB >> 29317601

Common basis for orofacial clefting and cortical interneuronopathy.

Lydia J Ansen-Wilson1,2, Joshua L Everson1,3, Dustin M Fink1, Henry W Kietzman1, Ruth Sullivan1, Robert J Lipinski4,5,6.   

Abstract

Orofacial clefts (OFCs) of the lip and/or palate are among the most common human birth defects. Current treatment strategies focus on functional and cosmetic repair but even when this care is available, individuals born with OFCs are at high risk for persistent neurobehavioral problems. In addition to learning disabilities and reduced academic achievement, recent evidence associates OFCs with elevated risk for a constellation of psychiatric outcomes including anxiety disorders, autism spectrum disorder, and schizophrenia. The relationship between these outcomes and OFCs is poorly understood and controversial. Recent neuroimaging studies in humans and mice demonstrate subtle morphological brain abnormalities that co-occur with OFCs but specific molecular and cellular mechanisms have not been investigated. Here, we provide the first evidence directly linking OFC pathogenesis to abnormal development of GABAergic cortical interneurons (cINs). Lineage tracing revealed that the structures that form the upper lip and palate develop in molecular synchrony and spatiotemporal proximity to cINs, suggesting these populations may have shared sensitivity to genetic and/or teratogenic insult. Examination of cIN development in a mouse model of nonsyndromic OFCs revealed significant disruptions in cIN proliferation and migration, culminating in misspecification of the somatostatin-expressing subgroup. These findings reveal a unified developmental basis for orofacial clefting and disrupted cIN development, and may explain the significant overlap in neurobehavioral and psychiatric outcomes associated with OFCs and cIN dysfunction. This emerging mechanistic understanding for increased prevalence of adverse neurobehavioral outcomes in OFC patients is the entry-point for developing evidence-based therapies to improve patient outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 29317601      PMCID: PMC5802454          DOI: 10.1038/s41398-017-0057-7

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  74 in total

Review 1.  Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders.

Authors:  John Jacob
Journal:  Epilepsia       Date:  2015-12-19       Impact factor: 5.864

2.  Evidence of olfactory deficits as part of the phenotypic spectrum of nonsyndromic orofacial clefting.

Authors:  Maureen A May; Carla A Sanchez; Frederic W B Deleyiannis; Mary L Marazita; Seth M Weinberg
Journal:  J Craniofac Surg       Date:  2015-01       Impact factor: 1.046

3.  GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Authors:  Jong H Yoon; Richard J Maddock; Ariel Rokem; Michael A Silver; Michael J Minzenberg; J Daniel Ragland; Cameron S Carter
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

Review 4.  Neuropsychological, behavioral, and academic sequelae of cleft: early developmental, school age, and adolescent/young adult outcomes.

Authors:  Lynn C Richman; Thomasin E McCoy; Amy L Conrad; Peg C Nopoulos
Journal:  Cleft Palate Craniofac J       Date:  2011-09-09

Review 5.  Gene-environment interactions in cortical interneuron development and dysfunction: A review of preclinical studies.

Authors:  Lydia J Ansen-Wilson; Robert J Lipinski
Journal:  Neurotoxicology       Date:  2016-12-05       Impact factor: 4.294

Review 6.  Interneuron dysfunction in psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Rev Neurosci       Date:  2012-01-18       Impact factor: 34.870

7.  Overdiagnosis and medication for attention-deficit hyperactivity disorder in children with cleft: diagnostic examination and follow-up.

Authors:  Lynn C Richman; Susan Ryan; Tammy Wilgenbusch; Tom Millard
Journal:  Cleft Palate Craniofac J       Date:  2004-07

8.  Definition of critical periods for Hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palate.

Authors:  Galen W Heyne; Cal G Melberg; Padydeh Doroodchi; Kia F Parins; Henry W Kietzman; Joshua L Everson; Lydia J Ansen-Wilson; Robert J Lipinski
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Characterization of subtle brain abnormalities in a mouse model of Hedgehog pathway antagonist-induced cleft lip and palate.

Authors:  Robert J Lipinski; Hunter T Holloway; Shonagh K O'Leary-Moore; Jacob J Ament; Stephen J Pecevich; Gary P Cofer; Francois Budin; Joshua L Everson; G Allan Johnson; Kathleen K Sulik
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

10.  Polymorphisms in FGF12, VCL, CX43 and VAX1 in Brazilian patients with nonsyndromic cleft lip with or without cleft palate.

Authors:  Sibele Nascimento de Aquino; Ana Camila Messetti; Elizabete Bagordakis; Hercílio Martelli-Júnior; Mario Sergio Oliveira Swerts; Edgard Graner; Ricardo D Coletta
Journal:  BMC Med Genet       Date:  2013-05-16       Impact factor: 2.103

View more
  3 in total

1.  The Brain in Oral Clefting: A Systematic Review With Meta-Analyses.

Authors:  Kinga A Sándor-Bajusz; Asaad Sadi; Eszter Varga; Györgyi Csábi; Georgios N Antonoglou; Szimonetta Lohner
Journal:  Front Neuroanat       Date:  2022-06-10       Impact factor: 3.543

2.  Articulation rehabilitation induces cortical plasticity in adults with non-syndromic cleft lip and palate.

Authors:  Zhen Li; Wenjing Zhang; Chunlin Li; Mengyue Wang; Songjian Wang; Renji Chen; Xu Zhang
Journal:  Aging (Albany NY)       Date:  2020-07-03       Impact factor: 5.682

3.  Developmental Toxicity Assessment of Piperonyl Butoxide Exposure Targeting Sonic Hedgehog Signaling and Forebrain and Face Morphogenesis in the Mouse: An in Vitro and in Vivo Study.

Authors:  Joshua L Everson; Miranda R Sun; Dustin M Fink; Galen W Heyne; Cal G Melberg; Kia F Nelson; Padydeh Doroodchi; Lydia J Colopy; Caden M Ulschmid; Alexander A Martin; Matthew T McLaughlin; Robert J Lipinski
Journal:  Environ Health Perspect       Date:  2019-10-23       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.